FDA Approval: Zidesamtinib and ROS1 NSCLC

FDA Approval: Zidesamtinib and ROS1 NSCLC

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephen Liu, Dr. Alexander Drilon, and Dr. Rosario Charo Garcia Campelo discuss the ARROS1 trial results, the drug's efficacy and safety profile, CNS activity, and where zidesamtinib may fit into current and future treatment strategies for ROS1-positive lung cancer. Guests: Alexander Drilon, MD Chief, Early Drug Development Service Attending Physician, Thoracic Oncology Service Memorial Sloan Kettering Cancer Center Professor, Weill Cornell Medical College Rosario Charo Garcia Campelo, MD Head of Medical Oncology and Thoracic Tumor Unit, Chair, University Hospital Head of the Oncology Research Group, Biomedical Research Institute A Coruna Spain

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(416)

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of t...

13 Okt 18min

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To ad...

9 Okt 37min

LCC in Korean WCLC 2026 Highlights

LCC in Korean WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...

6 Okt 45min

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and con...

5 Okt 24min

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and cl...

1 Okt 34min

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and...

29 Sep 44min

LCC in Czech: WCLC 2026 Highlights

LCC in Czech: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASL...

24 Sep 10min

LCC in Spanish: WCLC 2026 Highlights

LCC in Spanish: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC...

17 Sep 48min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
dekodet-2
sinnsyn
liberal-halvtime
rekommandert
rss-paradigmepodden
forskningno
rss-nysgjerrige-norge
fjellsportpodden
rss-rekommandert
nordnorsk-historie
grunnstoffene
noen-har-snakket-sammen
vett-og-vitenskap-med-gaute-einevoll
tidlose-historier
villmarksliv
rss-bondevennen
rss-overskuddsliv